P. Cane

发表

Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors.

T. Silander, D. Katzenstein, Y. Moreau, 2007, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Poor penetration of the male genital tract by HIV-1 protease inhibitors.

D. Pillay, G. Beards, P. Cane, 1999, AIDS.

Determinants of HIV-1 transmission in men who have sex with men: a combined clinical, epidemiological and phylogenetic approach

Anne M Johnson, Martin Fisher, Deenan Pillay, 2010, AIDS.

The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: seasonality and cross-protection

D J Nokes, P. Cane, G. Medley, 2005, Epidemiology and Infection.

Quantitation of hepatitis B lamivudine resistant mutants by real-time amplification refractory mutation system PCR.

P. Cane, N. Saunders, C. Teo, 2004, Journal of hepatology.

ARHAI: antiviral resistance.

D. Pillay, P. Cane, C. Tong, 2012, The Journal of antimicrobial chemotherapy.

Presence, persistence and effects of pre-treatment HIV-1 drug resistance variants detected using next generation sequencing: A Retrospective longitudinal study from rural coastal Kenya

P. Cane, J. Berkley, E. Sanders, 2019, PloS one.

HIV type 1 in a rural coastal town in Kenya shows multiple introductions with many subtypes and much recombination.

D. Pillay, P. Cane, J. Berkley, 2012, AIDS research and human retroviruses.

Persistence of HIV-1 Transmitted Drug Resistance Mutations

D. Webster, D. Pillay, Mark Hopkins, 2013, The Journal of infectious diseases.

Genomic analysis of respiratory syncytial virus infections in households and utility in inferring who infects the infant

P. Kellam, M. Cotten, P. Cane, 2019, Scientific Reports.

Factors associated with increased risk of progression to respiratory syncytial virus-associated pneumonia in young Kenyan children

P. Cane, G. Medley, E. Okiro, 2008, Tropical medicine & international health : TM & IH.

Drug-Resistant HIV-1 in the Semen of Men Receiving Antiretroviral Therapy with Acute Sexually Transmitted Infections

D. Pillay, A. Copas, P. Cane, 2002, Antiviral therapy.

Three Residues in HIV-1 Matrix Contribute to Protease Inhibitor Susceptibility and Replication Capacity

Deenan Pillay, Patricia A. Cane, C. Schiffer, 2010, Antimicrobial Agents and Chemotherapy.

Contribution of Gag and Protease to HIV-1 Phenotypic Drug Resistance in Pediatric Patients Failing Protease Inhibitor-Based Therapy

P. Cane, L. Morris, K. Sutherland, 2016, Antimicrobial Agents and Chemotherapy.

Coevolved Multidrug-Resistant HIV-1 Protease and Reverse Transcriptase Influences Integrase Drug Susceptibility and Replication Fitness

D. Pillay, P. Cane, J. Mbisa, 2021, Pathogens.

Recent sequence variation in probe binding site affected detection of respiratory syncytial virus group B by real-time RT-PCR

P. Cane, C. Agoti, D. Nokes, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Assessing the utility of minority variant composition in elucidating RSV transmission pathways

C. Worby, M. Cotten, P. Cane, 2018, bioRxiv.

Frequent Asymptomatic Respiratory Syncytial Virus Infections During an Epidemic in a Rural Kenyan Household Cohort

P. Cane, G. Medley, C. Agoti, 2015, The Journal of infectious diseases.

Whole genome analysis of local Kenyan and global sequences unravels the epidemiological and molecular evolutionary dynamics of RSV genotype ON1 strains

P. Lemey, P. Kellam, M. Cotten, 2018, bioRxiv.

Evolution of lamivudine-resistant hepatitis B virus and HIV-1 in co-infected individuals: an analysis of the CAESAR study

D. Pillay, D. Cooper, P. Cane, 2000, AIDS.

Additive Antiviral Effects of Lamivudine and α-Interferon in Chronic Hepatitis B Infection

D. Pillay, P. Cane, E. Elias, 1999, Antiviral Therapy.

Continuous Invasion by Respiratory Viruses Observed in Rural Households During a Respiratory Syncytial Virus Seasonal Outbreak in Coastal Kenya

P. Cane, G. Medley, C. Agoti, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Influence of age, severity of infection, and co-infection on the duration of respiratory syncytial virus (RSV) shedding

P. Cane, G. Medley, C. Agoti, 2014, Epidemiology and Infection.

Virucidal efficacy of guanidine-free inactivants and rapid test buffers against SARS-CoV-2

P. Cane, N. Woodford, M. Hannah, 2021, Scientific Reports.

Molecular Epidemiology of Human Rhinovirus Infections in Kilifi, Coastal Kenya

R. Myers, P. Cane, C. Agoti, 2012, Journal of medical virology.

Frequent polymerase errors observed in a restricted area of clones derived from the attachment (G) protein gene of respiratory syncytial virus

D. Matthews, P. Cane, C. Pringle, 1993, Journal of virology.

The Level and Duration of RSV-Specific Maternal IgG in Infants in Kilifi Kenya

P. Cane, G. Medley, D. Nokes, 2009, PloS one.

Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance.

D. Pillay, R. Myers, P. Cane, 2008, The Journal of antimicrobial chemotherapy.

HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya: a cross-sectional study

T. F. Rinke de Wit, P. Cane, J. Berkley, 2014, AIDS Research and Therapy.

Molecular epidemiology of respiratory syncytial virus

P. Cane, Patricia A. Cane, 2001, Reviews in medical virology.

Respiratory syncytial virus: an important cause of acute respiratory illness among young adults undergoing military training

P. Cane, M. O’Shea, G. Gray, 2007, Influenza and other respiratory viruses.

Use of Real-Time PCR and Fluorimetry To Detect Lamivudine Resistance-Associated Mutations in Hepatitis B Virus

D. Pillay, P. Cane, D. Mutimer, 1999, Antimicrobial Agents and Chemotherapy.

Evaluating the extent of potential resistance to pre‐exposure prophylaxis within the UK HIV‐1‐infectious population of men who have sex with men

A. Crook, D. Pillay, A. Phillips, 2012, HIV medicine.

Duration of shedding of respiratory syncytial virus in a community study of Kenyan children

P. Cane, G. Medley, E. Okiro, 2010, BMC infectious diseases.

Frameshifting and antigenic variation in respiratory syncytial virus.

P. Cane, 1993, Trends in microbiology.

Characterization of HIV type 1 clades in the Caribbean using pol gene sequences.

H. E. Vaughan, D. Pillay, R. Tedder, 2003, AIDS research and human retroviruses.

Respiratory viruses in adult liver transplant recipients.

D. Pillay, P. Cane, D. Mutimer, 1999, Transplantation.

The clinical spectrum of respiratory syncytial virus disease in The Gambia.

H. Whittle, S. Jaffar, P. Cane, 1998, The Pediatric infectious disease journal.

Effect of Transporter Modulation on the Emergence of Nelfinavir Resistance In Vitro

P. Cane, S. Khoo, A. Owen, 2007, Antiviral therapy.

Analysis of Hepatitis B Virus Quasispecies Changes during Emergence and Reversion of Lamivudine Resistance in Liver Transplantation

D. Pillay, G. Beards, P. Cane, 1999, Antiviral therapy.

Molecular analysis of respiratory syncytial virus reinfections in infants from coastal Kenya.

P. Cane, G. Medley, E. Okiro, 2006, The Journal of infectious diseases.

Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level

Eneida L. Hatcher, S. Lindstrom, I. Barr, 2021, Emerging infectious diseases.

Antibody response after RSV infection in children younger than 1 year of age living in a rural area of Mozambique

J. Saiz, P. Cane, P. Alonso, 2003, Journal of medical virology.

Respiratory Syncytial Virus

P. Cane, 2002 .

Evaluation of the antibody specificities of human convalescent‐phase sera against the attachment (G) protein of human respiratory syncytial virus: Influence of strain variation and carbohydrate side chains

P. Cane, C. Palomo, J. Melero, 2000, Journal of medical virology.

Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein.

P. Cane, B. García-Barreno, J. Melero, 1997, The Journal of general virology.

Analysis of the human serological immune response to a variable region of the attachment (G) protein of respiratory syncytial virus during primary infection

P. Cane, C. Pringle, C. Hart, 1996, Journal of medical virology.

Respiratory syncytial virus epidemiology in a birth cohort from Kilifi district, Kenya: infection during the first year of life.

P. Cane, G. Medley, E. Okiro, 2004, The Journal of infectious diseases.

Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease

A. Osterhaus, P. Cane, S. Chakrabarti, 2003, Bone Marrow Transplantation.

Spread and Evolution of Respiratory Syncytial Virus A Genotype ON1, Coastal Kenya, 2010–2015

P. Cane, C. Agoti, D. Nokes, 2017, Emerging infectious diseases.

Identification of mutations contributing to the reduced virulence of a modified strain of respiratory syncytial virus.

D. Matthews, P. Cane, J. Evans, 1996, Vaccine.

Intrapatient Variation of the Respiratory Syncytial Virus Attachment Protein Gene

P. Cane, G. Medley, C. Agoti, 2010, Journal of Virology.

Molecular Epidemiology and Evolution of RSV

P. Cane, 2006 .

Analysis of linear epitopes recognised by the primary human antibody response to a variable region of the attachment (G) protein of respiratory syncytial virus

P. Cane, 1997, Journal of medical virology.

Molecular epidemiology of respiratory syncytial virus: A review of the use of reverse transcription‐polymerase chain reaction in the analysis of genetic variability

P. Cane, C. Pringle, 1995, Electrophoresis.

Analysis of respiratory syncytial virus strain variation in successive epidemics in one city

D. Matthews, P. Cane, C. Pringle, 1994, Journal of clinical microbiology.

Molecular epidemiology of respiratory syncytial virus: rapid identification of subgroup A lineages.

P. Cane, C. Pringle, 1992, Journal of virological methods.

A large population sample of African HIV genomes from the 1980s reveals a reduction in subtype D over time associated with propensity for CXCR4 tropism

P. Kaleebu, A. Leigh Brown, P. Cane, 2022, Retrovirology.

High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation.

D. Pillay, P. Cane, P. Mcmaster, 1999, Journal of hepatology.

A restriction map of naphthalene catabolic plasmid pWW60-1 and the location of some of its catabolic genes

P. Cane, P. Williams, Peter A. Williams, 1986 .

Correlation Between Spontaneous Phenotypic Changes in Pseudomonas Strains with Changes in the Structure of Catabolic Plasmids: Experiences with TOL Plasmids

P. Cane, P. Williams, D. Jeenes, 1983 .

Dynamics of seminal plasma HIV-1 decline after antiretroviral treatment.

N. Ferguson, D. Pillay, R. Anderson, 2001, AIDS.

Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: risk factors and prognostic significance.

D. Pillay, P. Cane, D. Milligan, 2000, The Journal of infectious diseases.

The Source of Respiratory Syncytial Virus Infection In Infants: A Household Cohort Study In Rural Kenya

Graham F. Medley, Patricia A. Cane, Dorothy C. Koech, 2013, The Journal of infectious diseases.

Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya.

P. Cane, G. Medley, E. Okiro, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Use of a monoclonal antibody specific for wild-type yellow fever virus to identify a wild-type antigenic variant in 17D vaccine pools.

E. Gould, S. Higgs, P. Cane, 1989, The Journal of general virology.

Immunoblotting reveals differences in the accumulation of envelope protein by wild-type and vaccine strains of yellow fever virus.

E. Gould, P. Cane, 1989, The Journal of general virology.

Seroepidemiological study of respiratory syncytial virus in São Paulo State, Brazil

E. Massad, P. Cane, G. Medley, 1998, Journal of medical virology.

Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy.

D. Pillay, P. Cane, E. Elias, 2000, The Journal of infectious diseases.

Acute liver graft failure due to emergence of lamivudine resistant hepatitis B virus: rapid resolution during treatment with adefovir

D. Pillay, P. Cane, D. Mutimer, 2001, Gut.

Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient

D. Pillay, P. Cane, S. Hübscher, 2000, Gut.

Mutations in the hepatitis B virus DNA polymerase associated with antiviral resistance

D. Pillay, P. Cane, S. Locarnini, 1998 .

Complex genotypic changes during failure of HBV nucleoside analogue therapy

D. Pillay, D. Cooper, P. Cane, 2003 .

Failure of combination therapy with lamivudine and famciclovir following lamivudine monotherapy for hepatitis B virus infection in patients coinfected with human immunodeficiency virus-1.

D. Pillay, P. Cane, B. Gazzard, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Additive antiviral effects of lamivudine and alpha-interferon in chronic hepatitis B infection.

D. Pillay, P. Cane, E. Elias, 2000, Antiviral therapy.

Drug Resistance Genotypes Predict Response to Amprenavir-Containing Regimens in Highly Drug-Experienced HIV-1-Infected Patients

C. Leen, D. Pillay, C. Sabin, 2002, Antiviral therapy.

Viral Persistence After Liver Transplantation for Hepatitis B Virus: A Cross-Sectional Study

P. Cane, D. Mutimer, D. Freshwater, 2008, Transplantation.

Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV

B. Gazzard, C. Leen, C. Fraser, 2019, Journal of virus eradication.

Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration

Lynn Morris, Anne-Mieke Vandamme, Praphan Phanuphak, 2005, PLoS medicine.

Respiratory syncytial virus heterogeneity during an epidemic: analysis by limited nucleotide sequencing (SH gene) and restriction mapping (N gene).

P. Cane, C. Pringle, 1991, The Journal of general virology.

Analysis of Inactivation of SARS-CoV-2 by Specimen Transport Media, Nucleic Acid Extraction Reagents, Detergents, and Fixatives

P. Cane, N. Woodford, N. Green, 2020, Journal of Clinical Microbiology.

Expression and characterisation of the NS1 and NS2 proteins of respiratory syncytial virus.

P. Cane, J. Evans, C. Pringle, 1996, Virus research.

Recombinant strains of HIV type 1 in the United Kingdom.

D. Pillay, P. Cane, I. Tatt, 2001, AIDS research and human retroviruses.

Molecular diagnosis and analysis of Chikungunya virus.

P. Cane, R. Hewson, G. Lloyd, 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Long-Term Persistence of Primary Genotypic Resistance After HIV-1 Seroconversion

D. Pillay, P. Cane, J. Clarke, 2004, Journal of acquired immune deficiency syndromes.

Recent trends and patterns in HIV‐1 transmitted drug resistance in the United Kingdom

C. Fraser, D. Pillay, C. Sabin, 2016, HIV medicine.

Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study

D. Pillay, C. Sabin, A. Phillips, 2005, BMJ : British Medical Journal.

Whole genome analysis of local Kenyan and global sequences unravels the epidemiological and molecular evolutionary dynamics of RSV genotype ON1 strains

P. Lemey, P. Kellam, M. Cotten, 2018, bioRxiv.

Molecular epidemiology of human respiratory syncytial virus

P. Cane, C. Pringle, 1995 .

An Intensive, Active Surveillance Reveals Continuous Invasion and High Diversity of Rhinovirus in Households

P. Cane, G. Medley, C. Agoti, 2018, The Journal of infectious diseases.

Investigation of HIV-1 transmission events by phylogenetic methods: requirement for scientific rigour.

D. Pillay, P. Cane, S. Hué, 2005, AIDS.

HIV Type-1 Drug Resistance in Treatment-Naive Patients Monitored Using Minority Species Assays: A Systematic Review and Meta-Analysis

Ross J. Harris, D. Pillay, P. Cane, 2011, Antiviral therapy.

Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction

C. Fraser, E. Volz, D. Pillay, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV Type 1 transmission networks among men having sex with men and heterosexuals in Kenya.

T. F. Rinke de Wit, P. Cane, N. Faria, 2014, AIDS research and human retroviruses.

Genotypic resistance testing in routine clinical care

P. Cane, D. Dunn, Kate Coughlin, 2011, Current opinion in HIV and AIDS.

The effect of heat-treatment on SARS-CoV-2 viability and detection

P. Cane, C. Bruce, L. Easterbrook, 2021, Journal of Virological Methods.

The effect of heat on SARS-CoV-2 viability and RNA integrity as determined by plaque assay, virus culture and real-time RT-PCR

P. Cane, C. Bruce, L. Easterbrook, 2020, bioRxiv.

Identification of a transmission chain of HIV type 1 containing drug resistance-associated mutations.

D. Pillay, T. Wrin, C. Petropoulos, 2003, AIDS research and human retroviruses.

Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing

P. Kellam, M. Cotten, P. Cane, 2015, Journal of Virology.

Dynamics of HIV type 1 recombination following superinfection.

P. Cane, J. Mbisa, M. Fisher, 2013, AIDS research and human retroviruses.

Detection of drug resistance associated mutations in HIV primary infection within the UK.

D. Pillay, P. Cane, K. Porter, 2000, AIDS.

Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom

John P. Walsh, Andrew N. Phillips, Steve Kaye, 2007, AIDS.

Transmission patterns and evolution of respiratory syncytial virus in a community outbreak identified by genomic analysis

P. Kellam, M. Cotten, P. Cane, 2017, Virus evolution.

Analysis of the history and spread of HIV-1 in Uganda using phylodynamics

P. Kaleebu, P. Cane, C. Parry, 2015, The Journal of general virology.

HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy

Stéphane Hué, Deenan Pillay, Patricia A Cane, 2004, AIDS.

P. Cane, G. Medley, C. Agoti, 2012, The Journal of infectious diseases.

Evolution of subgroup A respiratory syncytial virus: evidence for progressive accumulation of amino acid changes in the attachment protein

P. Cane, C. Pringle, 1995, Journal of virology.

Inactivation analysis of SARS-CoV-2 by specimen transport media, nucleic acid extraction reagents, detergents and fixatives

P. Cane, N. Woodford, N. Green, 2020, bioRxiv.

Low prevalence of transmitted HIV type 1 drug resistance among antiretroviral-naive adults in a rural HIV clinic in Kenya.

T. F. Rinke de Wit, P. Cane, J. Berkley, 2013, AIDS research and human retroviruses.

Viral etiology of severe pneumonia among Kenyan infants and children.

P. Cane, J. Scott, D. Nokes, 2010, JAMA.

Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study

D. Pillay, C. Sabin, A. Phillips, 2012, BMJ : British Medical Journal.

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.

D. Katzenstein, N. Ford, R. Shafer, 2013, The Journal of infectious diseases.

Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data

C. Sabin, P. Cane, A. Tostevin, 2018, AIDS Research and Therapy.

No evidence for cross-contamination of dried blood spots excised using an office hole-punch for HIV-1 drug resistance genotyping.

D. Pillay, P. Cane, A. Buckton, 2009, The Journal of antimicrobial chemotherapy.

Lopinavir/ritonavir combined with twice-daily 400 mg indinavir: pharmacokinetics and pharmacodynamics in blood, CSF and semen.

P. Cane, S. Khoo, D. Back, 2004, The Journal of antimicrobial chemotherapy.

Enhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK

Ross J. Harris, N. Field, R. Myers, 2017, The Journal of antimicrobial chemotherapy.

Identification of variable domains of the attachment (G) protein of subgroup A respiratory syncytial viruses.

D. Matthews, P. Cane, C. Pringle, 1991, The Journal of general virology.

Molecular Evolutionary Dynamics of Respiratory Syncytial Virus Group A in Recurrent Epidemics in Coastal Kenya

P. Cane, G. Medley, C. Agoti, 2016, Journal of Virology.

Molecular epidemiology of respiratory syncytial virus in Kilifi district, Kenya

P. Cane, G. Medley, E. Okiro, 2004, Journal of medical virology.

Antigenic and genomic diversity of central European respiratory syncytial virus strains

P. Cane, C. Pringle, G. Mlinarić-galinović, 1998, Archives of Virology.

The Natural History of Respiratory Syncytial Virus in a Birth Cohort: The Influence of Age and Previous Infection on Reinfection and Disease

P. Cane, D. Nokes, C. Bottomley, 2012, American journal of epidemiology.

Rapid Spread and Diversification of Respiratory Syncytial Virus Genotype ON1, Kenya

P. Cane, C. Agoti, D. Nokes, 2014, Emerging infectious diseases.

The Plasmid-coded Metabolism of Naphthalene and 2-Methylnaphthalene in Pseudomonas Strains: Phenotypic Changes Correlated with Structural Modification of the Plasmid pWW60-1

P. Cane, P. Williams, 1982 .

Discordances between Interpretation Algorithms for Genotypic Resistance to Protease and Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Are Subtype Dependent

Lynn Morris, Anne-Mieke Vandamme, Praphan Phanuphak, 2006, Antimicrobial Agents and Chemotherapy.

Analysis of HIV‐1 variation in blood and semen during treatment and treatment interruption

D. Pillay, P. Cane, B. Choudhury, 2002, Journal of medical virology.

The HIV-1 protease substitution K55R: a protease-inhibitor-associated substitution involved in restoring viral replication.

R. Elston, D. Pillay, P. Cane, 2008, The Journal of antimicrobial chemotherapy.

Contribution of Gag and protease to variation in susceptibility to protease inhibitors between different strains of subtype B human immunodeficiency virus type 1.

D. Pillay, P. Cane, K. Sutherland, 2014, The Journal of general virology.

Changes in the Vif protein of HIV‐1 associated with the development of resistance to inhibitors of viral protease

P. Cane, M. McCrae, Melanie Adekale, 2005, Journal of medical virology.

Resistance-Associated Mutations in the Human Immunodeficiency Virus Type 1 Subtype C Protease Gene from Treated and Untreated Patients in the United Kingdom

D. Pillay, P. Cane, A. de Ruiter, 2001, Journal of Clinical Microbiology.

Incidence and severity of respiratory syncytial virus pneumonia in rural Kenyan children identified through hospital surveillance.

P. Cane, G. Medley, J. Scott, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vaccine Induced Herd Immunity for Control of Respiratory Syncytial Virus Disease in a Low-Income Country Setting

Graham F. Medley, Moses C. Kiti, Patricia A. Cane, 2015, PloS one.

Successive Respiratory Syncytial Virus Epidemics in Local Populations Arise from Multiple Variant Introductions, Providing Insights into Virus Persistence

P. Cane, G. Medley, C. Agoti, 2015, Journal of Virology.

The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants

P. Cane, D. Nokes, Charles J. Sande, 2014, Vaccine.

Kinetics of the Neutralizing Antibody Response to Respiratory Syncytial Virus Infections in a Birth Cohort

P. Cane, D. Nokes, G. Medley, 2013, Journal of medical virology.

Group- and Genotype-Specific Neutralizing Antibody Responses Against Respiratory Syncytial Virus in Infants and Young Children With Severe Pneumonia

P. Cane, G. Medley, D. Nokes, 2012, The Journal of infectious diseases.

Influenza Surveillance Among Children With Pneumonia Admitted to a District Hospital in Coastal Kenya, 2007–2010

P. Cane, L. Hammitt, J. Scott, 2012, The Journal of infectious diseases.

Improved Detection of Respiratory Viruses in Pediatric Outpatients with Acute Respiratory Illness by Real-Time PCR Using Nasopharyngeal Flocked Swabs

P. Cane, D. Nokes, P. Munywoki, 2011, Journal of Clinical Microbiology.

Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom

D. Pillay, P. Cane, K. Porter, 2001, BMJ : British Medical Journal.

New strategies for control of respiratory syncytial virus infection

P. Cane, J. Nokes, 2008, Current opinion in infectious diseases.

Detection and quantification of minority HIV isolates harbouring the D30N mutation by real-time PCR amplification.

P. Cane, S. Khoo, A. Owen, 2007, The Journal of antimicrobial chemotherapy.

Stability of transmitted drug-resistant HIV-1 species

P. Cane, 2005, Current opinion in infectious diseases.

Infection and Drug Resistance Dovepress Patterns of Resistance Development with Integrase Inhibitors in Hiv

Patricia A Cane, Jean L Mbisa, P. Cane, 2022 .

Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections

Martin Fisher, Caroline A Sabin, Gary Murphy, 2005, AIDS.

Emergence and Evolution of Enfuvirtide Resistance following Long-Term Therapy Involves Heptad Repeat 2 Mutations within gp41

D. Pillay, R. Myers, P. Cane, 2005, Antimicrobial Agents and Chemotherapy.

Increased detection of the HIV‐1 reverse transcriptase M184V mutation using mutation‐specific minority assays in a UK surveillance study suggests evidence of unrecognized transmitted drug resistance *

D. Pillay, P. Cane, Rj Harris, 2011, HIV medicine.

Enhanced surveillance of human immunodeficiency virus type 1 drug 2 resistance in recently infected MSM in the UK 3 4

Nigel, Ross J. Harris, R. Myers, 2016 .

Identification of accessory mutations associated with high-level resistance in HIV-1 reverse transcriptase

Hannah Green, David Dunn, Patricia A Cane, 2007, AIDS.

Comparison of strain‐specific antibody responses during primary and secondary infections with respiratory syncytial virus

P. Cane, G. Medley, E. Okiro, 2007, Journal of medical virology.

Identifying Infections with Respiratory Syncytial Virus by Using Specific Immunoglobulin G (IgG) and IgA Enzyme-Linked Immunosorbent Assays with Oral-Fluid Samples

P. Cane, G. Medley, E. Okiro, 2008, Journal of Clinical Microbiology.

Estimation of incidence of respiratory syncytial virus infection in schoolchildren using salivary antibodies

P. Cane, J. Ayres, K. Hammond, 2000, Journal of medical virology.

HIV drug resistance: genotypic assays and their possible applications.

D. Pillay, P. Cane, A. Ballard, 1998, Sexually transmitted infections.

Genotypic antiretroviral drug resistance testing at low viral loads in the UK

P. Cane, A. Geretti, E. Smit, 2008, HIV medicine.

Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation

B. Gazzard, D. Webster, C. Leen, 2015, HIV medicine.

New developments in HIV drug resistance.

P. Cane, 2009, The Journal of antimicrobial chemotherapy.

Nucleic acid differences between HIV-1 non-B and B reverse transcriptase and protease sequences at drug resistance positions

Soriano, D. Katzenstein, R. Shafer, 2003 .

Antigenic and Genetic Variability of Human Metapneumoviruses

A. Osterhaus, P. Cane, R. Fouchier, 2004, Emerging infectious diseases.

Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance

C. Leen, C. Fraser, E. Volz, 2018, The Journal of antimicrobial chemotherapy.

Evidence of Self-Sustaining Drug Resistant HIV-1 Lineages Among Untreated Patients in the United Kingdom.

D. Pillay, P. Cane, D. Dunn, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The effect of transmitted HIV-1 drug resistance on pre-therapy viral load

D. Pillay, A. Phillips, P. Cane, 2010, AIDS.

Phylodynamic and phylogeographic patterns of the HIV type 1 subtype F1 parenteral epidemic in Romania.

D. Pillay, R. Myers, P. Cane, 2012, AIDS research and human retroviruses.

Surveillance of HIV antiretroviral drug resistance in treated individuals in England: 1998-2000.

D. Pillay, P. Cane, A. Pozniak, 2004, The Journal of antimicrobial chemotherapy.

Understanding the transmission dynamics of respiratory syncytial virus using multiple time series and nested models

P. Cane, G. Medley, D. Nokes, 2007, Mathematical biosciences.

D. Matthews, P. Cane, C. Pringle, 1992, Virus research.

Respiratory Syncytial Virus Infection and Disease in Infants and Young Children Observed from Birth in Kiliﬁ District, Kenya

P. Cane, G. Medley, E. Okiro, 2007 .

HIV drug resistance testing.

P. Cane, 2011, Methods in molecular biology.

Molecular epidemiology of respiratory syncytial virus in The Gambia

H. Whittle, P. Cane, M. Weber, 1999, Epidemiology and Infection.

The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains

D. Pillay, P. Cane, C. Parry, 2011, Retrovirology.

Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors are subtype dependent

Lynn Morris, Anne-Mieke Vandamme, Praphan Phanuphak, 2004 .

Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors

P. Kaleebu, D. Pillay, P. Cane, 2015, AIDS research and human retroviruses.

Antigenic diversity of respiratory syncytial virus subgroup B strains circulating during a community outbreak of infection

P. Cane, C. Pringle, T. Chonmaitree, 1994, Journal of medical virology.

Subtype-specific differences in the development of accessory mutations associated with high-level resistance to HIV-1 nucleoside reverse transcriptase inhibitors.

P. Cane, D. Dunn, J. Mbisa, 2013, The Journal of antimicrobial chemotherapy.

Development of a highly sensitive semi-quantitative real-time PCR and molecular beacon probe assay for the detection of respiratory syncytial virus.

P. Cane, M. O’Shea, 2004, Journal of virological methods.

Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study

B. Gazzard, D. Webster, C. Leen, 2013, The Journal of antimicrobial chemotherapy.

British HIV Association guidelines for the routine investigation and monitoring of adult HIV‐1‐infected individuals 2011

C. Sabin, P. Cane, C. Orkin, 2012, HIV medicine.

Infection and Drug Resistance Dovepress Patterns of Resistance Development with Integrase Inhibitors in Hiv

P. Cane, J. Mbisa, Supang A Martin, 2022 .

Minimal variation in T-20 binding domain of different HIV-1 subtypes from antiretroviral-naive and -experienced patients.

Li Xu, Stephen Taylor, Stéphane Hué, 2002, AIDS.

Reduction of yellow fever virus mouse neurovirulence by immunization with a bacterially synthesized non-structural protein (NS1) fragment.

E. Gould, P. Cane, 1988, The Journal of general virology.

Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study

D. Pillay, C. Sabin, A. Phillips, 2012, BMJ : British Medical Journal.

Viral Persistence After Liver Transplantation for Hepatitis B Virus: A Cross-Sectional Study

P. Cane, D. Mutimer, D. Freshwater, 2008, Transplantation.

Whole genome analysis of local Kenyan and global sequences unravels the epidemiological and molecular evolutionary dynamics of RSV genotype ON1 strains

P. Lemey, P. Kellam, M. Cotten, 2018, Virus evolution.

Identification of group B respiratory syncytial viruses that lack the 60‐nucleotide duplication after six consecutive epidemics of total BA dominance at coastal Kenya

P. Cane, G. Medley, C. Agoti, 2013, Influenza and other respiratory viruses.

The Natural History of Respiratory Syncytial Virus in a Birth Cohort: The Influence of Age and Previous Infection on Reinfection and Disease

P. Cane, E. Okiro, D. Nokes, 2012, American journal of epidemiology.